The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres

Autor: Thakral NK, Ray AR, Bar-Shalom D, Eriksson AH, Majumdar DK

Publikováno v: International Journal of Nanomedicine, Vol 2011, Iss default, Pp 1057-1068 (2011)

Naveen K Thakral1, Alok R Ray1,2, Daniel Bar-Shalom3, André Huss Eriksson4, Dipak K Majumdar51Centre for Biomedical Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, India; 2Biomedical Engineering Unit, All India Institute of

Externí odkaz: https://doaj.org/article/da96f314c4bc42b5a45e491ed15b0582

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group.

Autor: Bauer A; Sunovion Pharmaceuticals, Marlborough, MA, 01752, USA., Berben P; UCB Pharma SA, Braine-l'Alleud, Belgium., Chakravarthi SS; Bristol Myers Squibb, New Brunswick, NJ, 08901, USA., Chattorraj S; GlaxoSmithKline, Collegeville, PA, 19426, USA., Garg A; Eli Lilly and Company, Indianapolis, IN, USA., Gourdon B; Biogen, Cambridge, MA, 02142, USA., Heimbach T; Merck & Co., Inc., Rahway, NJ, 07065, USA., Huang Y; AbbVie Inc., North Chicago, IL, 60064, USA., Morrison C; GlaxoSmithKline, Collegeville, PA, 19426, USA., Mundhra D; GlaxoSmithKline, Collegeville, PA, 19426, USA., Palaparthy R; Gilead Sciences, Foster City, CA, 94404, USA., Saha P; GlaxoSmithKline, Collegeville, PA, 19426, USA., Siemons M; Janssen R&D, a Division of Janssen Pharmaceutica NV, Beerse, Belgium., Shaik NA; Gilead Sciences, Foster City, CA, 94404, USA., Shi Y; AbbVie Inc., North Chicago, IL, 60064, USA., Shum S; Takeda Development Center Americas, Inc., Cambridge, MA, 02139, USA., Thakral NK; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Urva S; Eli Lilly and Company, Indianapolis, IN, USA., Vargo R; Merck & Co., Inc., Rahway, NJ, 07065, USA., Koganti VR; Bristol Myers Squibb, New Brunswick, NJ, 08901, USA. venkat.koganti@bms.com., Barrett SE; Merck & Co., Inc., Rahway, NJ, 07065, USA. stephanie_barrett@merck.com.

Publikováno v: Pharmaceutical research [Pharm Res] 2023 Jul; Vol. 40 (7), pp. 1601-1631. Date of Electronic Publication: 2023 Feb 22.

Harmonizing Biopredictive Methodologies Through the Product Quality Research Institute (PQRI) Part I: Biopredictive Dissolution of Ibuprofen and Dipyridamole Tablets.

Autor: Tsume Y; Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey, USA. yasuhiro.tsume@merck.com., Ashworth L; AstraZeneca, Macclesfield, UK., Bermejo M; Miguel Hernandez University, Alicante, Spain., Cheng J; University of Minnesota, Minneapolis, Minneapolis, USA., Cicale V; Bristol-Myers Squibb Company, New Brunswick, New Jersey, USA., Dressman J; Fraunhofer Institute for Translational Medicine Pharmacology, Frankfurt, Germany.; Goethe Universität, Frankfurt, Germany., Fushimi M; Sawai Pharmaceutical Co. Ltd., Osaka, Japan., Gonzalez-Alvarez I; Miguel Hernandez University, Alicante, Spain., Guo Y; University of Minnesota, Minneapolis, Minneapolis, USA., Jankovsky C; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA., Lu X; Bristol-Myers Squibb Company, New Brunswick, New Jersey, USA., Matsui K; Sawai Pharmaceutical Co. Ltd., Osaka, Japan., Patel S; Merck & Co., Inc., 126 E Lincoln Avenue, Rahway, New Jersey, USA., Sanderson N; AstraZeneca, Macclesfield, UK., Sun CC; University of Minnesota, Minneapolis, Minneapolis, USA., Thakral NK; Schrodinger Inc., New York, New York, USA., Yamane M; Sawai Pharmaceutical Co. Ltd., Osaka, Japan., Zöller L; Goethe Universität, Frankfurt, Germany.

Publikováno v: The AAPS journal [AAPS J] 2023 Apr 21; Vol. 25 (3), pp. 45. Date of Electronic Publication: 2023 Apr 21.

Using Tiny-TIM Dissolution and In Silico Simulation to Accelerate Oral Product Development of a BCS Class II Compound.

Autor: Luo L; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut, 06877, USA. laibin_2.luo@boehringer-ingelheim.com., Thakral NK; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut, 06877, USA. naveen.k.thakral@gmail.com., Schwabe R; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut, 06877, USA., Li L; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut, 06877, USA.; Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, 4849 Calhoun Road, Houston, Texas, 77204, USA., Chen S; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, Connecticut, 06877, USA.

Publikováno v: AAPS PharmSciTech [AAPS PharmSciTech] 2022 Jul 01; Vol. 23 (6), pp. 185. Date of Electronic Publication: 2022 Jul 01.